F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Rifaximin

Page 1 of 1 ( 22 items )
<<
1
>>

1	Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship 9/25/2025 11:24:01 AM \| Browse: 89 \| Download: 102
2	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 85 \| Download: 371
3	Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis 4/25/2025 8:23:02 AM \| Browse: 82 \| Download: 486
4	Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease 1/23/2024 9:31:45 AM \| Browse: 533 \| Download: 1419
5	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 270 \| Download: 992
6	Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy 1/4/2023 5:53:01 AM \| Browse: 543 \| Download: 1336
7	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 612 \| Download: 1159
8	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 642 \| Download: 2227
9	Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care 5/14/2020 3:43:04 AM \| Browse: 1072 \| Download: 2528
10	Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study 1/13/2020 11:27:13 AM \| Browse: 1097 \| Download: 2346
11	Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy 1/3/2020 1:28:57 AM \| Browse: 1011 \| Download: 2018
12	Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese 6/27/2019 10:40:37 AM \| Browse: 1017 \| Download: 2555
13	Current and future pharmacological therapies for managing cirrhosis and its complications 2/27/2019 4:11:15 AM \| Browse: 1311 \| Download: 2061
14	Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity 12/20/2017 2:49:19 AM \| Browse: 1508 \| Download: 2813
15	Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation 7/7/2017 11:41:16 AM \| Browse: 1390 \| Download: 2257
16	Advances in cirrhosis: Optimizing the management of hepatic encephalopathy 12/10/2015 3:04:00 PM \| Browse: 1331 \| Download: 2115
17	Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver 12/2/2015 12:01:00 PM \| Browse: 1562 \| Download: 1959
18	Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 11/24/2015 3:55:00 PM \| Browse: 1458 \| Download: 2499
19	Rifaximin and Crohn's disease 9/12/2014 8:41:00 PM \| Browse: 1270 \| Download: 1266
20	Clinical update for the diagnosis and treatment of Clostridium difficile infection 9/5/2014 2:44:00 PM \| Browse: 1589 \| Download: 1651
21	Second and third line treatment options for Helicobacter pylori eradication 9/3/2014 10:14:00 AM \| Browse: 1345 \| Download: 1312
22	Irritable bowel syndrome: A concise review of current treatment concepts 8/25/2014 5:12:00 PM \| Browse: 1344 \| Download: 1451

Page 1 of 1 ( 22 items )
<<
1
>>

1	Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship 9/25/2025 11:24:01 AM \| Browse: 89 \| Download: 102
2	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 85 \| Download: 371
3	Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis 4/25/2025 8:23:02 AM \| Browse: 82 \| Download: 486
4	Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease 1/23/2024 9:31:45 AM \| Browse: 533 \| Download: 1419
5	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 270 \| Download: 992
6	Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy 1/4/2023 5:53:01 AM \| Browse: 543 \| Download: 1336
7	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 612 \| Download: 1159
8	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 642 \| Download: 2227
9	Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care 5/14/2020 3:43:04 AM \| Browse: 1072 \| Download: 2528
10	Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study 1/13/2020 11:27:13 AM \| Browse: 1097 \| Download: 2346
11	Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy 1/3/2020 1:28:57 AM \| Browse: 1011 \| Download: 2018
12	Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese 6/27/2019 10:40:37 AM \| Browse: 1017 \| Download: 2555
13	Current and future pharmacological therapies for managing cirrhosis and its complications 2/27/2019 4:11:15 AM \| Browse: 1311 \| Download: 2061
14	Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity 12/20/2017 2:49:19 AM \| Browse: 1508 \| Download: 2813
15	Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation 7/7/2017 11:41:16 AM \| Browse: 1390 \| Download: 2257
16	Advances in cirrhosis: Optimizing the management of hepatic encephalopathy 12/10/2015 3:04:00 PM \| Browse: 1331 \| Download: 2115
17	Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver 12/2/2015 12:01:00 PM \| Browse: 1562 \| Download: 1959
18	Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 11/24/2015 3:55:00 PM \| Browse: 1458 \| Download: 2499
19	Rifaximin and Crohn's disease 9/12/2014 8:41:00 PM \| Browse: 1270 \| Download: 1266
20	Clinical update for the diagnosis and treatment of Clostridium difficile infection 9/5/2014 2:44:00 PM \| Browse: 1589 \| Download: 1651
21	Second and third line treatment options for Helicobacter pylori eradication 9/3/2014 10:14:00 AM \| Browse: 1345 \| Download: 1312
22	Irritable bowel syndrome: A concise review of current treatment concepts 8/25/2014 5:12:00 PM \| Browse: 1344 \| Download: 1451